Found "AI":  1,093 results
Analysis: U.S. governors make risky political bet on healthcare funds
                    (Reuters) – Republican governors bent on rejecting the healthcare law’s expanded insurance coverage for millions of low-income Americans may see their gambit backfire if their party fails to sweep the November elections.Five governors have vowed to opt out of the Medicaid expansion for low-income pe                
                
                
            EU agency lifts lid on drug data secrets
                    (Reuters) – Europe’s medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information.The change is a landmark in transparency that puts E                
                
                
            GSK in weekend talks to buy Human Genome: sources
                    (Reuters) – GlaxoSmithKline is holding talks this weekend with Human Genome Sciences to agree a deal to acquire it for some $2.6 billion, after pursuing the U.S. biotech company for three months, sources familiar with the situation said on Sunday.The British pharmaceutical giant could sweeten its pr                
                
                
            Vast F.D.A. Effort Tracked E-Mails of Its Scientists
                    WASHINGTON — A wide-ranging surveillance operation by the Food and Drug Administration against a group of its own scientists used an enemies list of sorts as it secretly captured thousands of e-mails that the disgruntled scientists sent privately to members of Congress, lawyers, labor officials, jou                
                
                
            Drug Approved to Fight H.I.V. Infection
                    The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of H.I.V. infection, a milestone in the 30-year battle against the virus that causes AIDS. The agency approved Truvada, a pill made by Gilead Sciences, as a preventive measure for people who are at high risk                
                
                
            AstraZeneca starts new study of heart drug versus rival
                    (Reuters) – AstraZeneca is to conduct a new global clinical trial of key new heart drug Brilinta involving 11,500 patients with peripheral artery disease, Britain’s second biggest drugmaker said on Tuesday.Peripheral artery disease affects around 27 million people in Europe and North America, with s                
                
                
            Rational use of Health Technology: A collaborative program between the Consortium of Thai Medical Schools and Health Intervention and Technology Assessment Program
                    This short training aims to equip administrator and medical instructors with skill in the selection of appropriate health technologies, and to give guidance in doing a relevant research that benefit the country.  201-203-2553Capacity building,Consortium of Thai Medical Schools,ความร่วมมือ                
                
                
            HIV-prevention drug Truvada approved by US
                    US health regulators have for the first time approved a drug to prevent HIV infection.Truvada can be used by those at high risk of infection and anyone who may engage in sexual activity with HIV-infected partners, said the Food and Drug Administration (FDA).Studies showed the drug reduced the risk o                
                
                
            Polypill ‘could save thousands’ of lives
                    “polypill” combining a statin with blood pressure drugs could prevent thousands of heart attacks and strokes every year, according to researchers.A UK study of 84 over-50s, published in the journal PLoS One, showed the pill could cut blood pressure and levels of “bad” cholesterol.They called for the                
                
                
            Lesley Griffiths defends civil servants on NHS report
                    Wales’ health minister says it was “entirely appropriate” for her civil servants to be in contact with the author of a report into the NHS.Lesley Griffiths defended emails between senior officials and the academic behind the report.Officials were also challenged about why local health boards thought                
                
                
            
        
  10 / Page
        
      
      